Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics & Pharmacoproteomics is the study of the use of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation & stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficiency and Membrane transport proteins.

  • Protein aggregation and stability in biopharmaceuticals
  • New discoveries in genomic targets
  • Various drug responses due to genetic polymorphisms
  • Drug dosage formulations
  • Drug safety and its efficacy
  • Membrane transport proteins

Related Conference of Pharmacogenomics & Pharmacoproteomics

July 13-14, 2018

13th International Conference on Structural Biology

Toronto | Ontario | Canada
July 23-24, 2018

International Conference on Forensic Research & Technology

Melbourne , Australia
August 06-07, 2018

International Conference on Structural Biology

Dubai, UAE
eeee

August 27-28, 2018

5th International Conference on Glycobiology, Lipids & Proteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-18, 2018

Annual Epigenetics Congress

Chicago, USA
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Biophysics

Los Angeles, California, USA
December 05-06, 2018

4th International Conference on Genetic and Protein Engineering

Chicago, Illinois, USA
Nov 19-20, 2018

15th World Congress on Structural Biology

Lisbon, Portugal

Pharmacogenomics & Pharmacoproteomics Conference Speakers